Overview

Reduced Immunosuppression in Older Renal Transplant Recipients With Trugraf®/TRAC Monitoring (RIOT Trial): A Prospective, Randomized, Multicenter Trial.

Status:
RECRUITING

Trial end date:
2031-03-31

Target enrollment:

Participant gender:

Summary

The purpose of this research is to determine the safety and efficacy of withdrawing MMF (Mycophenolate Mofetil) in kidney transplant recipients who are 55 years or older at the time of receiving a kidney transplant. We are comparing them to patients who receive the standard of care Mycophenolate Mofetil.

Phase:

PHASE4

Details

Lead Sponsor:

Mayo Clinic

Collaborators:

Eurofins
Transplant Genomics, Inc.

Treatments:

Mycophenolic Acid